These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1312259)

  • 21. Amyloid-β 1-24 C-terminal truncated fragment promotes amyloid-β 1-42 aggregate formation in the healthy brain.
    Mazzitelli S; Filipello F; Rasile M; Lauranzano E; Starvaggi-Cucuzza C; Tamborini M; Pozzi D; Barajon I; Giorgino T; Natalello A; Matteoli M
    Acta Neuropathol Commun; 2016 Oct; 4(1):110. PubMed ID: 27724899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Cerebrolysin on amyloid-beta deposition in a transgenic model of Alzheimer's disease.
    Rockenstein E; Mallory M; Mante M; Alford M; Windisch M; Moessler H; Masliah E
    J Neural Transm Suppl; 2002; (62):327-36. PubMed ID: 12456076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M
    Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease.
    Urbanc B; Cruz L; Le R; Sanders J; Ashe KH; Duff K; Stanley HE; Irizarry MC; Hyman BT
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):13990-5. PubMed ID: 12374847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High order W02-reactive stable oligomers of amyloid-β are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-β monomer.
    Robb E; Perez K; Hung LW; Masters CL; Barnham KJ; Cherny RA; Bush AI; Adlard PA; Finkelstein DI
    J Alzheimers Dis; 2015; 44(1):69-78. PubMed ID: 25182735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative evaluation of treatments with 17β-estradiol and its brain-selective prodrug in a double-transgenic mouse model of Alzheimer's disease.
    Tschiffely AE; Schuh RA; Prokai-Tatrai K; Prokai L; Ottinger MA
    Horm Behav; 2016 Jul; 83():39-44. PubMed ID: 27210479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease.
    Timmer NM; Herbert MK; Kleinovink JW; Kiliaan AJ; De Waal RM; Verbeek MM
    Neuropathol Appl Neurobiol; 2010 Oct; 36(6):478-86. PubMed ID: 20831743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer's disease-like cerebral amyloidosis.
    Ferretti MT; Merlini M; Späni C; Gericke C; Schweizer N; Enzmann G; Engelhardt B; Kulic L; Suter T; Nitsch RM
    Brain Behav Immun; 2016 May; 54():211-225. PubMed ID: 26872418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease.
    Toyama H; Ye D; Ichise M; Liow JS; Cai L; Jacobowitz D; Musachio JL; Hong J; Crescenzo M; Tipre D; Lu JQ; Zoghbi S; Vines DC; Seidel J; Katada K; Green MV; Pike VW; Cohen RM; Innis RB
    Eur J Nucl Med Mol Imaging; 2005 May; 32(5):593-600. PubMed ID: 15791432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brainwide distribution and variance of amyloid-beta deposits in tg-ArcSwe mice.
    Lillehaug S; Syverstad GH; Nilsson LN; Bjaalie JG; Leergaard TB; Torp R
    Neurobiol Aging; 2014 Mar; 35(3):556-64. PubMed ID: 24126157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late running is not too late against Alzheimer's pathology.
    Herring A; Münster Y; Metzdorf J; Bolczek B; Krüssel S; Krieter D; Yavuz I; Karim F; Roggendorf C; Stang A; Wang Y; Hermann DM; Teuber-Hanselmann S; Keyvani K
    Neurobiol Dis; 2016 Oct; 94():44-54. PubMed ID: 27312772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-n oligomers as therapeutic targets of Alzheimer's disease.
    Ono K; Yamada M
    J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.
    Xiang Y; Bu XL; Liu YH; Zhu C; Shen LL; Jiao SS; Zhu XY; Giunta B; Tan J; Song WH; Zhou HD; Zhou XF; Wang YJ
    Acta Neuropathol; 2015 Oct; 130(4):487-99. PubMed ID: 26363791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease.
    Huang XT; Qian ZM; He X; Gong Q; Wu KC; Jiang LR; Lu LN; Zhu ZJ; Zhang HY; Yung WH; Ke Y
    Neurobiol Aging; 2014 May; 35(5):1045-54. PubMed ID: 24332448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperspectral imaging signatures detect amyloidopathy in Alzheimer's mouse retina well before onset of cognitive decline.
    More SS; Vince R
    ACS Chem Neurosci; 2015 Feb; 6(2):306-15. PubMed ID: 25354367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time sequence of oxidative stress in the brain from transgenic mouse models of Alzheimer's disease related to the amyloid-β cascade.
    Belkacemi A; Ramassamy C
    Free Radic Biol Med; 2012 Feb; 52(3):593-600. PubMed ID: 22172527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for the accumulation of Abeta immunoreactive material in the human brain and in transgenic animal models.
    Cuello AC; Allard S; Ferretti MT
    Life Sci; 2012 Dec; 91(23-24):1141-7. PubMed ID: 22705309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitrosylation of Vesicular Transporters in Brain of Amyloid Precursor Protein/Presenilin 1 Double Transgenic Mice.
    Wang Y; Zhou Z; Tan H; Zhu S; Wang Y; Sun Y; Li XM; Wang JF
    J Alzheimers Dis; 2017; 55(4):1683-1692. PubMed ID: 27911305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.